Men with chronic lung disease have consistently lower testosterone levels compared to healthy men.
By simply increasing these levels, the risk of further deterioration and functional disability may be reduced.
With chronic obstructive pulmonary disease being one of the leading causes of death and disability, further studies into the benefits, risks and cost-effectiveness of testosterone therapy are needed.
Read more at Western Sydney University